Related Experiment Video
Updated: Aug 17, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Urological complications of COVID-19: a systematic review
Luca Schiliró Tristão1, Rafael Bresler1, Victoria Andrade Modesto1
1Departamento de Medicina Baseada em Evidências, Faculdade de Ciências Médicas de Santos (FCMS-UNILUS), Santos, SP, Brasil.
Purpose:
COVID-19 continues to be an urgent World issue. Receptors of angiotensin converting enzyme 2 (ACE2), gateway of SARS-CoV-2, are present in the lungs, bladder, prostate, and testicles. Therefore, these organs face high risk of damage caused by the virus and this mechanism may explain non-respiratory symptoms of the disease.
Materials And Methods:
This systematic review, guided by the PRIMSA statement, was proposed to elucidate possible urological complications of COVID-19. Searches were carried out in Medline (PubMed), Cochrane (CENTRAL), Embase, MedRxiv and LILACS. Bias analysis was made using the specific Newcastle-Ottawa Scale for each study design.
Results:
Search was carried out until April 2022, and 8,477 articles were identified. Forty-nine of them were included in this systematic review. There is evidence that lower urinary tract symptoms and acute scrotum may be signs of COVID-19 in men, although in a small proportion. Also, the disease may have a transitory impact on male fertility, evidenced by several alterations in sperm counts. However, it must be clarified whether this impact is transitory, or may last for longer periods. Several patients showed reduction of total value of testosterone. Two authors linked low levels of testosterone with worse outcomes of COVID-19, suggesting that the hormone may be used as an early biomarker of the severity of the disease. Moreover, it is extremely unlikely that SARS-CoV-2 is transmitted by semen.
Conclusion:
This systematic review identified possible repercussions of COVID-19 in the urinary as well as in the male reproductive system.
Insights
COVID-19 can affect the urinary tract and male reproductive system, potentially causing symptoms like lower urinary tract issues and impacting male fertility. Testosterone levels may indicate disease severity.
Area of Science:
- Urology
- Infectious Diseases
- Reproductive Medicine
Background:
- COVID-19, caused by SARS-CoV-2, utilizes ACE2 receptors found in the lungs, bladder, prostate, and testicles, posing risks to these organs.
- Non-respiratory symptoms of COVID-19 may be linked to the virus's impact on these ACE2-rich areas.
Approach:
- A systematic review guided by the PRIMSA statement was conducted to identify urological complications associated with COVID-19.
- Searches encompassed major databases (Medline, PubMed, CENTRAL, Embase, MedRxiv, LILACS) up to April 2022.
- Bias analysis was performed using the Newcastle-Ottawa Scale.
Key Points:
- Lower urinary tract symptoms and acute scrotum can be manifestations of COVID-19 in men.
- COVID-19 may temporarily affect male fertility, indicated by changes in sperm parameters.
- Reduced testosterone levels were observed in some patients, potentially serving as a severity biomarker.
Conclusions:
- COVID-19 can have repercussions on the male urinary and reproductive systems.
- Further research is needed to determine the long-term effects of COVID-19 on male fertility.
- Transmission of SARS-CoV-2 via semen is considered highly unlikely.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
04:25Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
Published on: December 15, 2023
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management